ACA StandardHealth with Health Choice — Prior Authorization Grid and Code Updates
Customize your policy alerts
Sign up for all blue cross blue shield - arizona policy alerts
Know when blue cross blue shield - arizona releases new policies or updates existing guidance.
Monitor payer policy activity
Governs prior authorization (PA) rules, required forms, and PA code updates for ACA StandardHealth with Health Choice members and providers (including out-of-network). Affects providers and facilities rendering services to members under this product.
Multiple HCPCS/J-codes and Q-codes were added to require prior authorization effective 1/12/2026.
Prior Authorization Coverage Criteria
Prior Authorization Coverage Criteria (partial)
Prior authorization is required for the following services and codes (partial list shown in this file segment):
PA requirement nodes
Prior authorization requirement applies to listed services, procedure and supply codes as shown below.
Prior authorization criteria and provisions
Listed services and codes require prior authorization in the settings specified unless otherwise noted.
PA requirements
Prior authorization requirements and place/provider rules:
PA-required codes
Prior authorization requirement for listed codes
Prior Authorization Requirement
Prior authorization requirement for listed procedure codes
Prior Authorization Requirements (excerpt)
Services listed require prior authorization as indicated; imaging authorizations must be obtained through eviCore.
PA requirements and exceptions
Prior authorization and billing rules for codes and specialty medications on the PA grid
Synagis PA criterion
Synagis (palivizumab) specific rule
General PA and billing rule
General requirement for provider‑administered specialty medications
Coverage mapping (informational)
This document segment is a drug‑to‑code mapping used in the payer's prior authorization/billing processes; no explicit coverage criteria are provided in these chunks.
Codes and Coding Notes (HCPCS / CPT / J-/Q- listings)
| 28344 | Listed procedural code referenced in cosmetic/advanced imaging group |
| 30400-30462 | Range of rhinoplasty/related nasal procedure codes referenced |
| 81163-81540 (range of listed genetic test codes and others) | Multiple genetic testing CPT codes and related codes are listed throughout chunks 36-38 |
| 95722-95726 | EEG testing series (codes shown individually in document) |
| L2280-L8046 | Multiple L- and S- HCPCS codes for prosthetics/orthotics (many specific codes enumerated) |
| J0178 | Aflibercept, 1 mg (Eylea) |
| J0180 | Agalsidase beta, 1 mg (Fabrazyme) |
| J9015 | Aldesleukin, per single use vial (Proleukin) |
| J7345 | Aminolevulinic acid for topical administration (Levulan/Ameluz) |
| J9061 | Amivantamab-vmjw, 2 mg (Rybrevant) |
| J0348 | Anidulafungin, 1 mg (Eraxis) |
| J9022 | Atezolizumab, 10 mg (Tecentriq) |
| J7208 | Antihemophilic factor, recombinant, 1 iu (Jivi) |
| J9035 | Bevacizumab, 10 mg (Avastin) |
| J9145 | Daratumumab, 10 mg (Darzalex) |
| J2356 | Tezspire |
| J3240 | Thyrotropin alpha (Thyrogen) 0.9 mg |
| J3245 | Tildrakizumab (Ilumya) 1 mg |
| J9329 | Tislelizumab-jsgr (Tevimbra) 1 mg |
| Q2042 | Tisagenlecleucel (Kymriah) up to 600M CAR-positive viable T cells |
| J9273 | Tisotumab vedotin-tftv (Tivdak) 1 mg |
| J3262 | Tocilizumab (Actemra) 1 mg |
| Q5135 | Tocilizumab-aazg, biosimilar (Tyenne) 1 mg |
| Q5133 | Tocilizumab-bavi, biosimilar (Tofidence) 1 mg |
| J1304 | Tofersen (Qalsody) 1 mg |
Provider Actions, Submission Instructions, and Operational Rules
PA contact and resources
For Behavioral Health Residential Care and other PA inquiries visit the payer PA guidance pages and use the contact channels below.
- PA guidance and forms: www.azblue.com/aca-standardhealth-health-choice/providers/pa-guidelines
- Provider manual (Chapter 6 Authorizations & Notifications): www.azblue.com/aca-standardhealth-health-choice/providers/provider-manual
- Behavioral Health Residential Care fax: 480-760-4732
General PA directives
Follow the general PA directives for ACA StandardHealth with Health Choice: submit required assessments, limit one service per form, confirm member eligibility, and note authorization validity and out-of-network requirements.
- Submit Maternal High Risk Assessment with PA requests
- Only one medical or pharmacy service may be requested per PA form
- Member must be enrolled in ACA StandardHealth with Health Choice at time of service
- Authorizations are valid for 90 days from date issued
- All out-of-network providers/facilities require prior authorization for all services
PA required services list (partial)
Obtain prior authorization for the extensive list of services and CPT/HCPCS codes shown in the grid — ECT and rTMS are explicitly listed examples requiring PA.
- ECT and rTMS are listed as codes that require PA
- See the imaging/procedure code list at the end of the file for the full enumerated list
PA for non-participating providers
Prior authorization is required for all non-participating (out‑of‑network) providers and hospitals for the services listed on the grid.
- PA required for all non-participating providers and hospitals (applies to listed codes)
Cosmetic/plastic procedures PA
Prior authorization is required for the listed cosmetic, plastic and esthetic procedures; the grid explicitly names examples that require PA.
- Examples requiring PA: collagen injections, rhinoplasty, otoplasty, scar revision, keloid treatments, surgical repair of gynecomastia, pectus deformity, mammoplasty, abdominoplasty, dermabrasion, Botox injections, vein ligation/ablation
DME & diabetic supplies PA
Durable medical equipment (DME) and diabetic supplies listed on the grid require prior authorization; specific HCPCS/E-codes are identified in the document.
Genetic testing / experimental PA
Genetic testing CPT codes and certain experimental/investigational procedure codes identified in the grid require prior authorization.
- Multiple genetic testing codes (e.g., ranges such as 81163–81540 and many specific CPT codes) are listed as PA-required
General prior authorization requirement
The grid states that prior authorization is required for listed services and codes — 'PA Required for all Services' appears as a provision in the document.
- Providers must obtain PA for services and codes listed on the PA grid unless an explicit exception applies
Inpatient admission notification
All facilities must notify HCS of inpatient admissions; the document provides a fax number for inpatient notifications.
- Fax inpatient notifications to: 480-760-4732
Performer specialty restriction for nerve conduction studies
Nerve conduction studies may only be performed by Neurologists or Physical Medicine & Rehabilitation physicians; the document notes no prior authorization is required for these studies when performed by those specialists.
- Performer restriction: only Neurologists and Physical Medicine & Rehab Physicians may perform nerve conduction studies
- No PA required for nerve conduction studies when performed by those specialists
EEG and Out-of-Network PA requirement
EEG testing codes (including 95722–95726) require prior authorization when performed in Ambulatory Surgery Centers and when billed by non‑participating providers or hospitals.
Genetic testing / Neurologic devices PA requirement
Prior authorization is required for genetic testing, neurologic stimulation devices, and numerous nerve-related procedure codes as listed in the grid.
- Neurologic stimulation devices and associated genetic testing CPT codes are listed as PA-required in multiple sections
Out-of-network PA provisions
For Out‑of‑Network / Non‑Participating providers and facilities, prior authorization is required for the listed codes on the PA grid; emergency services are excluded from this requirement.
- PA is required for listed codes for Out of Network / Non Par Providers & Facilities
- Exclusion: emergency services are not subject to the out‑of‑network PA requirement
Prior authorization required
The grid enumerates numerous procedure and supply codes (CPT, HCPCS, L‑codes) that require prior authorization; obtain PA before service delivery for listed codes.
EEG Prior Authorization
EEG testing codes are listed repeatedly in the grid as requiring prior authorization; PA is required for listed EEG codes and for services delivered by non‑participating providers.
- EEG series (e.g., 95722–95726) are cited as PA-required
Prosthetics/Orthotics Prior Authorization
Prior authorization is required for prosthetics, orthotics, and many L‑ and S‑HCPCS codes listed on the grid; follow the grid guidance when submitting requests.
Imaging prior authorization via eviCore
Authorizations for MRI, MRA, CT and PET must be obtained through eviCore; requests may be initiated on www.evicore.com or by phone.
- eviCore website: www.evicore.com
- Phone: 888-693-3211 (7am–8pm CST)
PA required for listed services and non-participating providers
Prior authorization is required for the prosthetics/orthotics and therapy CPT/HCPCS codes listed; PA is also required for these services when provided by non‑participating providers or hospitals.
Routine office-based procedures exception/statement
Routine office‑based procedures do not require authorization unless otherwise listed on the PA grid; however the grid contains a provision that states 'PA Required for all Services' for specific entries.
- Do not require authorization unless otherwise listed on this grid; check grid entries for exceptions where PA is required
Prior Authorization Requirement and Instructions
Providers should use the BCBSAZ Health Choice PA grid and the payer website to obtain the required PA medical request form and instructions for submission.
- PA medical request form and instructions: www.azblue.com/aca-standardhealth-health-choice/providers/paguidelines
- Specialty medication administration/billing guidance is available on the same site
Synagis PA Exception
Synagis (palivizumab) does not require prior authorization for members under two years of age; providers may obtain Synagis via CVS Caremark Specialty Pharmacy or using 'Buy and Bill'.
- No PA required for Synagis for members < 2 years
- Procurement options: CVS Caremark Specialty Pharmacy or 'Buy and Bill'
PA and billing instructions for specialty medications
Specialty medications administered in contracted provider offices or outpatient facilities require prior authorization and must be billed as a medical claim; indicate 'Buy and Bill' or CVS Caremark options on the PA form when applicable.
- Provider‑administered specialty medications billed as medical claims
- Use 'Buy and Bill' or CVS Caremark Specialty Pharmacy options and indicate on PA request
Synagis PA exception and submission details
For Synagis cases requiring submission (other than the age‑under‑2 exemption), submit a complete Medical PA request form with supporting documentation to the fax number provided in the grid.
- Fax for Medical PA requests (other Synagis cases): 1-877-422-8120
- Include supporting documentation with the Medical PA request form
Prior authorization grid notice
The PA grid is effective 1/26/26 and shows a revision date of 12/10/25; use the grid as the authoritative list of codes that require prior authorization.
- Grid effective date: 1/26/26
- Grid revision date: 12/10/25
Code listing (no prior auth rules in segment)
The HCPCS J‑ and Q‑code listing in this section is provided for billing and drug reference; this segment does not include additional authorization rules.
- J/Q code list and drug names are included for billing reference only; no new PA rules in this listing
Definitions and Key Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.